YONGCHENG SONG to Molecular Targeted Therapy
This is a "connection" page, showing publications YONGCHENG SONG has written about Molecular Targeted Therapy.
Connection Strength
0.250
-
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J Hematol Oncol. 2020 05 13; 13(1):50.
Score: 0.142
-
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood. 2016 08 18; 128(7):971-81.
Score: 0.108